SeQuent Scientific Limited (SeQuent), which has businesses across Animal Health (Alivira) & Analytical Services, has announced the inauguration of a new state-of-the-art multifaceted and dedicated Animal Health R&D centre at Ambernath in Mumbai.
This unique centre with strong injectable focus has capabilities to develop products of 8 different dosage forms including injectable solutions & suspensions, tablets, oral solutions & suspensions, granules, powders and premixes.
Equipped with the best Lab to Pilot infrastructure, a team of 20+ research professionals with over 100+ years of experience, the centre is working on several differentiated products to cater to Alivira’s Global market needs. In addition to product development, the team has developed capabilities to handle complex radio-labelled ecotoxicity studies and In-vitro palatability, tissue residue, bio-equivalence studies across a spectrum of livestock and companion animals.
Commenting on the development, Manish Gupta, Managing Director of SeQuent Scientific Limited said: “We are pleased to announce the addition of a new animal health R&D centre at Ambernath equipped with state-of-the-art global infrastructure and multifaceted capability. The facility brings under one roof one of the most comprehensive R & D capabilities in the animal health space and will help us to increase our footprint in the regulated market.” He also added “We also filed for the first and World’s largest livestock injectable developed at this location and plans are afoot to file for 3 more injectables in FY 21.”
SeQuent Scientific Limited is headquartered in Mumbai, with a global footprint, operates in the domains of Animal Health (Alivira) and Analytical Services. SeQuent has eight manufacturing facilities based in India, Spain, Germany, Brazil and Turkey with approval from global regulatory bodies including USFDA, EUGMP, WHO, TGA among others. Its Vizag facility is India’s first and only USFDA approved facility for veterinary APIs.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.